Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K. Saha, Nabeel Bardeesy, John D. Gordan et al.|Cancer Discovery|2016Cited by 163
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancerHayley Donnella, Sourav Bandyopadhyay, James T. Webber et al.|Nature Chemical Biology|2018Cited by 92
Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem CellsGarry L. Coles, Julien Sage, Sandra Cristea et al.|Cancer Cell|2020Cited by 86
Synthetic Lethal Targeting of <i>ARID1A</i> -Mutant Ovarian Clear Cell Tumors with DasatinibRowan Miller, Alan Ashworth, Josephine Joel et al.|Molecular Cancer Therapeutics|2016Cited by 85
Molecular Cross-Validation for Single-Cell RNA-seqJoshua Batson, James T. Webber, Löıc A. Royer|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 31